Azitra, Inc. (AZTR)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
AZTR Insider Trading Activity
AZTR Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $10,034 | 1 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Staskey Norm | Chief Financial Officer | 1 | $10,034 | 0 | $0 | $10,034 |
About Azitra, Inc.
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human …
Insider Activity of Azitra, Inc.
Over the last 12 months, insiders at Azitra, Inc. have bought $10,034 and sold $0 worth of Azitra, Inc. stock.
On average, over the past 5 years, insiders at Azitra, Inc. have bought $7.3M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Staskey Norm (Chief Financial Officer) — $10,034.
The last purchase of 47,600 shares for transaction amount of $10,034 was made by Staskey Norm (Chief Financial Officer) on 2024‑03‑29.
List of Insider Buy and Sell Transactions, Azitra, Inc.
| 2024-03-29 | Staskey Norm | Chief Financial Officer | 47,600 0.2506% | $0.21 | $10,034 | -87.28% | ||
| 2024-02-13 | Salva Francisco D. | President and CEO | 333,300 2.4975% | $0.30 | $99,990 | -97.42% | ||
| 2024-02-13 | Whitfill Travis | Chief Operating Officer | 15,000 0.1124% | $0.30 | $4,500 | -97.42% | ||
| 2024-02-13 | Staskey Norm | Chief Financial Officer | 3,300 0.0247% | $0.30 | $990 | -97.42% | ||
| 2023-06-21 | Kreis Leslie W. | 10 percent owner | 2.3M – | $3.15 | $7.24M | -73.83% | ||
| 2023-06-21 | Fletcher Aaron G.L. | 10 percent owner | 2.3M – | $3.15 | $7.24M | -73.83% |
Insider Historical Profitability
| Staskey Norm | Chief Financial Officer | 51100 0.3411% | $16,811.90 | 2 | 0 | <0.0001% |
| Salva Francisco D. | President and CEO | 338300 2.2584% | $111,300.70 | 1 | 0 | <0.0001% |
| Whitfill Travis | Chief Operating Officer | 334500 2.2331% | $110,050.50 | 1 | 0 | <0.0001% |
Historical Insider Profitability vs. Competitors
$18,881,323 | 88 | -48.96% | $6.27M | |
$31,129 | 22 | -11.96% | $6.19M | |
$51,865 | 17 | -38.70% | $6.45M | |
$1,558,469 | 16 | -26.98% | $4.76M | |
$139,855 | 11 | -32.84% | $5.57M |
AZTR Institutional Investors: Active Positions
| Increased Positions | 7 | +100% | 188,986 | +137.73% |
| Decreased Positions | 3 | -42.86% | 70,258 | -51.2% |
| New Positions | 4 | New | 105,272 | New |
| Sold Out Positions | <1 | Sold Out | 48,804 | Sold Out |
| Total Postitions | 11 | +57.14% | 255,943 | +86.53% |
AZTR Ownership Change vs Market
Institutional Investor Ownership
| Virtu Financial Llc | $23.00 | 0.42% | 63,180 | +41,866 | +196.43% | 2024-12-31 |
| National Bank Of Canada /Fi/ | $14.00 | 0.27% | 40,000 | +35,000 | +700% | 2024-12-31 |
| Ubs Group Ag | $14.00 | 0.26% | 38,726 | +38,726 | New | 2024-12-31 |
| Renaissance Technologies Llc | $13.00 | 0.24% | 36,573 | +36,573 | New | 2024-12-31 |
| Geode Capital Management, Llc | $12.00 | 0.23% | 33,948 | +6,848 | +25.27% | 2024-12-31 |
| Xtx Topco Ltd | $7.00 | 0.13% | 19,071 | +19,071 | New | 2024-12-31 |
| Two Sigma Securities, Llc | $5.00 | 0.09% | 12,735 | -21,424 | -62.72% | 2024-12-31 |
| Susquehanna International Group, Llp | $4.00 | 0.07% | 10,902 | +10,902 | New | 2024-12-31 |
| Tower Research Capital Llc (Trc) | $0 | 0.01% | 769 | -30 | -3.75% | 2024-12-31 |
| Bank Of America Corp /De/ | $0 | 0% | 39 | 0 | 0% | 2024-12-31 |